ATLASATLAS fair value
₹6,599
Below fair value · 24% discount
Range: ₹5,939–₹7,259Fair valuePrice
Alkem Laboratories (ALKEM.NSE)
Alkem Laboratories share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · National Stock Exchange of India · India
₹5,030▲ +1.68%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
53%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Alkem Laboratories in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Alkem Laboratories
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Alkem Laboratories's fair value at about ₹6,599 per share (reasonable range: ₹5,939 to ₹7,259). At ₹5,030, the stock trades 24% below it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Alkem Laboratories a 53% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹4,873 and ₹5,234; in 9 out of 10, between ₹4,574 and ₹5,577. Estimated annual volatility is 20%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹598B
- Market cap (USD)
- $6.3B
- P/E ratio
- 27.4
- Dividend yield
- 0.40%
- 52-week high
- ₹5,934
- 52-week low
- ₹4,811
- Revenue (12 months)
- ₹151B
- Operating margin
- 17.8%
- Net margin
- 14.3%
- Beta
- 0.29
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Alkem Laboratories sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks ALKEM.NSE has traded between ₹4,811 and ₹5,934. Today it is 15.2% below that high and 5% above its low.
On the business: net margin is 14.3%; it trades at 27.4 times earnings.
Its beta is 0.29: it tends to move less than the market.
About the company
Alkem Laboratories Ltd. operates as a prominent pharmaceutical company based in India. The primary function of Alkem Laboratories is the development, manufacture, and distribution of a wide range of pharmaceutical formulations and active pharmaceutical ingredients (APIs).
Want to see everything about Alkem Laboratories?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Alkem Laboratories (ALKEM.NSE) fair value?
About ₹6,599 per share according to ATLAS (reasonable range: ₹5,939 to ₹7,259). With the stock at ₹5,030, it is 24% below it.
What is the chance ALKEM.NSE goes up next month?
53%: close to a coin flip. In half of the simulated outcomes, ALKEM.NSE ends the month between ₹4,873 and ₹5,234.
How big is Alkem Laboratories and what is its P/E ratio?
Alkem Laboratories's market capitalization is ₹598B. Its price-to-earnings (P/E) ratio is 27.4: you pay ₹27.4 for each ₹1.00 of yearly earnings.
Does Alkem Laboratories pay a dividend?
Yes. ALKEM.NSE's current dividend yield is 0.40% at today's price (₹5,030).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer